22 Acquisition drivers The Legacy IPC system is a smart acquisition…strategically valuable, low-risk, and positioned to deliver both immediate impact and sustained growth • A game-changing MedTech acquisition that accelerates participation in the connected IPC niche by avoiding costly and prolonged in-house development • Legacy is a regulatoryapproved device, trusted and endorsed by top global healthcare institutions • A fully developed, market-ready system designed for swift scalability without the need for ground-up development • Incorporating a silent pump, reusable elements, and real-time compliance tracking, Legacy provides advanced capabilities that distinguish it from existing market alternatives • By integrating Legacy’s technology, value propositions are elevated with a next-generation IPC solution that is both patient-centric and sustainable • Leveraging Legacy’s patented technologies will serve as a catalyst for advancing technological leadership • A wireless and appenabled portable device, Legacy is optimised for home use, which aligns with the rapid growth of outpatient and remote care models in modern healthcare • Legacy extends hospitalbased performance of IPC devices into a bestin-class, connected system that serves both hospital and homecare environments • Legacy provides a strategic entry point into digital health and remote patient monitoring • Increasing demand for eco-friendly, reusable medical devices aligns with Legacy’s commitment to sustainability • Legacy’s digital compliance tracking supports value-based care models and reimbursement regimes, which are continuing to gain prominence • Opportunity to capture demand fuelled by ageing populations and the growth of home healthcare • Legacy’s compact, easy-to-use design drives higher patient adherence, and reduces VTE events and costs…which is appealing to both payers and providers • With Legacy, new distribution pathways open in outpatient, rehab, and telehealth—fastgrowing markets driving the future of healthcare • Potential to drive incremental growth by cross-selling and bundling Legacy e.g. alongside established surgical and vascular propositions Expansion into connected home / community care IPC Addressing market trends and regulatory drivers Commercial and financial upside Innovation to complement existing portfolios Accelerated time to market and reduced R&D risk • Adds a techforward offering that strengthens differentiation in tenders…which will resonate with the many health systems prioritising digital health and sustainability • Opportunity to not only defend market position but to grow it against incumbents A strengthened competitive position
RkJQdWJsaXNoZXIy NTI5NzM=